Additionally, we observed the potential beneficial effects of CCB-targeted drugs on cSVD imaging markers and of CETP-targeted, LPL-targeted and GIPR obesity-targeted drugs on LS. The gene discussed is LPL; the disease is obesity due to melanocortin 4 receptor deficiency.